For patient No.1 we longitudinally quantified CTC levels including HER2 expression with the CellSearch® system (Menarini Silicon Biosystems) and compared the results to routine tumor imaging by Positron Emission Tomography – Computed Tomography (PET/CT). This evidence concerns the gene ERBB2 and neoplasm.